#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Ann Brady Email
Chief Business Officer . Avectas
Maynooth University,
LocationPrimary Email
How to contact Ann Brady
Join and see Ann's contact info for free!Current Roles
Employees:
48Revenue:
$3.7MAbout
Avectas is a cell engineering business focused on improving the cost, manufacturing and patient outcomes for the next generation of cellular therapies. Avectas is developing a unique delivery technology platform, Solupore®, to enable the ex-vivo manufacture of gene modified cell therapy products, with partners. Solupore® is a patented, non-viral, cell engineering technology that permeabilizes the target cell membrane and allows efficient transfer of cargo into cells whilst retaining very high levels of cell viability and functionality. The Solupore® technology is designed for use with mRNA, DNA, and proteins, including gene editing tools such as CRISPR. Solupore® achieves excellent engineering efficiencies for delivery of these payloads to primary T cells and NK cells for immuno-oncology and gene editing applications. Avectas is currently developing the clinical (cGMP) technology embodiment while enhancing its dataset, implementing its commercialization strategy and building out the team.Avectas Address
245 First StreetMaynooth University, null